Loading provider…
Loading provider…
Hematology & Oncology Physician in La Jolla, CA
NPI: 1184680399Primary Practice Location
SCRIPPS GREEN HOSPITAL
10666 N Torrey Pines Rd, La Jolla, CA
Primary Employer
Scripps Clinic
scripps.org
HQ Phone
Get M.D. Alan's Phone Numberphone_androidMobile
Get M.D. Alan's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
1986 - 2027
PA State Medical License
1985 - 1990

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Medical Oncology
Scripps Clinic/Scripps Green Hospital
Fellowship • Medical Oncology
1987 - 1990
Albert Einstein Healthcare Network
Residency • Internal Medicine
1984 - 1987
University of Cape Town Faculty of Medicine
Medical School
Until 1982
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 646 | 1,236 |
| 2 | 99204New patient office or other outpatient visit, 45-59 minutes | 234 | 234 |
| 3 | 99215Established patient office or other outpatient, visit typically 40 minutes | 120 | 238 |
| 4 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 96 | 202 |
| 5 | 96413Infusion of chemotherapy into a vein up to 1 hour | 80 | 360 |
In Support of a Patient-Driven Initiative and Petition to Lower the High Price of Cancer Drugs
Authors: Philip Kantoff, Richard Larson, Susan Cohn, Susan O'Brien, Deepa Bhojwani, Sundararajan Rajkumar, Ranjana Advani, Thomas Kipps, Morie Gertz, Clifford Hudis, John Byrd, James Foran, James Allison, George Canellos, Michael Link, Nancy Berliner, Linda Bosserman, Stephen Forman, Jordan Gutterman, Richard Vanetten, Forrest Stewart, Mikkael Sekeres, Ayalew Tefferi, Sagar Lonial, Louise Strong, Hagop Kantarjian, Robert Bast, Massimo Cristofanilli, Andrew Zelenetz, Gerardo Colon-Otero, Andrew Schafer, Ravi Bhatia, Martin Tallman, Scott Lippman, Daniel Deangelo, Peter Greenberg, Sergio Giralt, Carolyn Runowicz, Hope Rugo, Asher Chanan-Khan
Journal: Mayo Clin Proc
Publication Date: 2015-07-23
2-Chlorodeoxyadenosine (2-CdA): A Potent Chemotherapeutic and Immunosuppressive Nucleoside.
Authors: Lawrence Piro
Journal: Leuk Lymphoma
Antibodies selected from combinatorial libraries block a tumor antigen that plays a key role in immunomodulation.
Authors: John Mcwhirter, Anke Kretz-Rommel, Alan Saven, Toshiaki Maruyama, Kathleen N. Potter, C. Ian Mockridge, E. Prenn Ravey, Fenghua Qin, Katherine S. Bowdish
Publication Date: 2006-01
Lead Sponsor: Scripps Health
Intervention / Treatment: DRUG: Low dose vemurafenib plus rituximab
Lead Sponsor: Scripps Health
Collaborators: Bristol-Myers Squibb, Celgene Corporation
Intervention / Treatment: DRUG: dasatinib and lenalidomide
Lead Sponsor: Memorial Sloan Kettering Cancer Center
Collaborators: National Cancer Institute (NCI), Northwestern University, Dana-Farber Cancer Institute, Ohio State University, Northwell Health, Scripps Clinic
Intervention / Treatment: DRUG: Vemurafenib